
Philipp Hartrampf
Articles
-
May 17, 2024 |
mdpi.com | Sarah Schumann |Harry Scherthan |Philipp Hartrampf |Lukas Göring
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Dec 11, 2023 |
europeanurology.com | Philipp Hartrampf |Steven P. Rowe |Martin G. Pomper |Molecular Imaging
We would like to thank Anand and colleagues for their letter on Prostate-Specific Membrane Antigen-Reporting and Data System (PSMA-RADS) version (v) 2.0 and would like to provide a point-by-point reply. Overall, we agree that further research and refinement of PSMA positron emission tomography reporting are necessary. To read this article in full you will need to make a paymentSubscribe to European UrologyReferencesProstate-Specific Membrane Antigen Reporting and Data System version 2.0.Eur Urol.
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma
Dec 1, 2023 |
jnm.snmjournals.org | Johannes Duell |Andreas Bück |Philipp Hartrampf |Wiebke Schlötelburg
MATERIALS AND METHODSIn this retrospective, single-center study, we included 100 patients (women, 55/100 [55%]; mean age, 66 ± 13 y; age range, 24–86 y) with MZL who had been imaged with [68Ga]Ga-pentixafor as part of routine care (primary staging, 92/100 [92%]; restaging, 8/100 [8%]). In all cases, MZL was histologically confirmed. All subjects provided written consent for the conducted procedures. The local ethics committee waived the need for further approval (number 20220414 01).
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma
Oct 5, 2023 |
jnm.snmjournals.org | Johannes Duell |Andreas Bück |Philipp Hartrampf |Wiebke Schlötelburg
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma Johannes Duell, Andreas K. Buck, Philipp E. Hartrampf, Wiebke Schlötelburg, Simone Schneid, Alexander Weich, Niklas Dreher, Constantin Lapa, Malte Kircher, Takahiro Higuchi, Samuel Samnick, Sebastian E. Serfling, Markus Raderer, Leo Rasche, Hermann Einsele, Max S. Topp, Aleksander Kosmala, Rudolf A.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →